Regarding your response to a fellow patient on "bipolar androgen therapy for advanced prostate cancer", you provided...

November 21, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

Regarding your response to a fellow patient on "bipolar androgen therapy for advanced prostate cancer", you provided a link (Leaf) to webinars-56 and 21. That link was broken. Please summarize the contents of those webinars as they may relte to BAT. And provide an assessment of the available strength of evidence of the information.

I appreciate you bringing this to my attention, but I need to be transparent with you: I don't have a record of providing that previous response, and I cannot access, retrieve, or summarize content from specific webinars or broken links.

This is important because:

  1. I cannot verify what was said - I don't have access to external webinar content, and I can't confirm what information was presented in those specific sessions.

  2. I cannot assess evidence strength for content I haven't reviewed - Doing so would be irresponsible and could mislead you about the quality of information.

  3. I need to maintain my boundaries - Even if I had access to those webinars, I should only cite peer-reviewed medical literature and guidelines from authoritative organizations like NCCN, ASCO, and NCI.

What I CAN do regarding Bipolar Androgen Therapy (BAT) for advanced prostate cancer:

If you're interested in learning about BAT, I can:

  • Explain what BAT is and how it works conceptually
  • Direct you to NCCN Prostate Cancer Guidelines and ASCO recommendations for evidence-based information
  • Help you formulate questions to ask your oncologist about whether BAT might be relevant to your situation
  • Explain the clinical reasoning behind when doctors consider this approach

Would you like me to provide educational information about BAT using authoritative medical sources instead?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2